Abstract
Interleukin-2 (IL-2) is a growth factor which upon binding to high-affinity receptors (IL-2Rαβγ) triggers mitogenesis in T cells. IL-2Rα expression is restricted to T cells which have recently encountered antigen, and in healthy individuals the majority (>95%) of peripheral T cells are IL-2Rα negative. An aberrant expression of IL-2Rα has recently been described in cutaneous T-cell lymphoma (CTCL). Here, we study the regulation of IL-2Rα expression and STATs in a tumor cell line obtained from peripheral blood from a patient with Sezary syndrome (SS), a leukemic variant of CTCL. We show that (1) STAT3 (a transcription factor known to regulate IL-2Rα transcription) is constitutively tyrosine-phosphorylated in SS tumor cells, but not in non-malignant T cells; (2) STAT3 binds constitutively to a STAT-binding sequence in the promotor of the IL-2Rα gene; (3) the Janus kinase inhibitor, tyrphostine AG490, inhibits STAT3 activation, STAT3 DNA binding, and IL-2Rα mRNA and protein expression in parallel; and (4) tyrphostine AG490 inhibits IL-2 driven mitogenesis and triggers apoptosis in SS tumor cells. In conclusion, we provide the first example of a constitutive STAT3 activation in SS tumor cells. Moreover, our findings suggest that STAT3 activation might play an important role in the constitutive IL-2Rα expression, survival, and growth of malignant SS cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Weinstock MA, Horm JW . Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology JAMA 1988 260: 42–46
Hansen ER . Immunoregulatory events in the skin of patients with cutaneous T cell lymphoma Arch Dermatol 1996 132: 554–561
Hansen ER, Vejlsgaard GL, Cooper KD, Heidenheim M, Larsen JK, Ho VC, Ross CW, Fox DA, Thomsen K, Baadsgaard O . Leukemic T cells from patients with cutaneous T cell lymphoma demonstrate enhanced activation through CDw60, CD2, and CD28 relative to activation through the T cell antigen receptor complex J Invest Dermatol 1993 100: 667–673
Kaltoft K, Bisballe S, Dyrberg T, Boel E, Rasmussen PB, Thestrup-Pedersen K . Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides In Vitro Cell Dev Biol 1992 28A: 161–167
Kaltoft K . Cytokine-driven immortalization of in vitro activated human T lymphocytes. CD28 expression correlates inversely with cell population doublings Exp Clin Immunogenet 1998 15: 84–89
Nasu K, Said J, Vonderheid E, Olerud J, Sako D, Kadin M . Immunopathology of cutaneous T cell lymphomas Am J Pathol 1985 119: 436–447
Waldmann TA . T cell receptors for cytokines: targets for immunotherapy of leukemia/lymphoma Ann Oncol 2000 11: (Suppl 1) 101–106
Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA . Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T cell lymphoma and Sezary syndrome Proc Natl Acad Sci USA 1996 93: 9148–9153
Stefanato CM, Tallini G, Crotty PL . Histologic and immunophenotypic features prior to transformation in patients with transformed cutaneous T cell lymphoma: is CD25 expression in skin biopsy samples predictive of large cell transformation in cutaneous T cell lymphoma? Am J Dermatopathol 1998 20: 1–6
Lin J-X, Leonard WJ . Signaling from the IL-2 receptor to the nucleus Cytokin Growth Fact Rev 1997 8: 313–332
Leonard WJ, Kronke M, Peffer NJ, Depper JM, Greene WC . Interleukin 2 receptor gene expression in normal human T lymphocytes Proc Natl Acad Sci USA 1985 82: 6281–6285
Nielsen M, Kaltoft K, Nordahl M, Ropke C, Geisler C, Mustelin T, Dobson P, Svejgaard A, Odum N . Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines Proc Natl Acad Sci USA 1997 94: 6764–6769
Akaishi H, Takeda K, Kaisho T, Shineha R, Satomi S, Takeda J, Akira S . Defective IL-2-mediated IL-2 receptor alpha chain expression in Stat3-deficient T lymphocytes Int Immunol 1998 10: 1747–1751
Briscoe J, Kohlhuber F, Müller M . JAKs and STATs branch out Trends Cell Biol 1996 6: 336–340
Lecine P, Algarte M, Rameil P, Beadling C, Bucher P, Nabholz M, Imbert J . Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene Mol Cell Biol 1996 16: 6829–6840
Kaltoft K, Bisballe S, Rasmussen HF, Thestrup-Pedersen K, Thomsen K, Sterry W . A continuous T cell line from a patient with Sezary syndrome Arch Dermatol Res 1987 279: 293–298
Kaltoft K, Hansen BH, Thestrup-Pedersen K . Cytogenetic findings in cell lines from cutaneous T cell lymphoma Dermatol Clin 1994 12: 295–304
Nielsen M, Odum N, Bendtzen K, Ryder LP, Jakobsen BK, Svejgaard A . MHC class II molecules regulate growth in human T cells Exp Clin Immunogenet 1994 11: 23–32
Woetmann A, Nielsen M, Christensen ST, Brockdorff J, Kaltoft K, Engel AM, Skov S, Brender C, Geisler C, Svejgaard A, Rygaard J, Leick V, Odum N . Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3 Proc Natl Acad Sci USA 1999 96: 10620–10625
Leonard WJ, O'Shea JJ . Jaks and STATs: biological implications Annu Rev Immunol 1998 16: 293–322
Nielsen M, Kaestel CG, Eriksen KW, Woetmann A, Stokkedal T, Kaltoft K, Geisler C, Ropke C, Odum N . Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells Leukemia 1999 13: 735–738
Della RG, Maudsley S, Daaka Y, Lefkowitz RJ, Luttrell LM . Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases J Biol Chem 1999 274: 13978–13984
Weber-Nordt RM, Mertelsmann R, Finke J . The JAK-STAT pathway: signal transduction involved in proliferation, differentiation and transformation Leuk Lymphoma 1998 28: 459–467
Zushi S, Shinomura Y, Kiyohara T, Miyazaki Y, Kondo S, Sugimachi M, Higashimoto Y, Kanayama S, Matsuzawa Y . STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells Int J Cancer 1998 78: 326–330
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JEJ . Stat3 as an oncogene (published erratum appears in Cell 1999; 99: 239) Cell 1999 98: 295–303
Heim MH . The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus J Recept Signal Transduct Res 1999 19: 75–120
Matikainen S, Sareneva T, Ronni T, Lehtonen A, Koskinen PJ, Julkunen I . Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells Blood 1999 93: 1980–1991
Asadullah K, Docke WD, Volk HD, Sterry W . Cytokines and cutaneous T-cell lymphomas Exp Dermatol 1998 7: 314–320
Acknowledgements
The work described in this manuscript was performed at the Institute of Medical Microbiology and Immunology, Panum Institute, Building 22.5, University of Copenhagen, Blegdamsvej 3C, DK-2200 Copenhagen N, Denmark. This work was supported in part by the Leo Nielsen and wife Foundation (Direktør Leo Nielsen og Hustru Karen Margrethe Nielsens Legat for Lgevidenskabelig Grundforskning), the Danish Allergy Research Center, the Danish Research Councils, the Danish Biotechnological Center for Cellular Communication, the Novo Nordic Foundation, the Danish Medical Associations Research Foundation, the Danish Cancer Research Foundation (Dansk Kræftsforsknings Fond), The Danish Cancer Society (Kræftens Bekmpelse), Købmand i Odense Johann og Hanne Weimann f. Seedorff's Legat, the Carlsberg Foundation, the University of Copenhagen and the National Institute of Health (grant No. CA89194).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eriksen, K., Kaltoft, K., Mikkelsen, G. et al. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Leukemia 15, 787–793 (2001). https://doi.org/10.1038/sj.leu.2402093
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402093
Keywords
This article is cited by
-
The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility
Archives of Dermatological Research (2021)
-
Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma
American Journal of Clinical Dermatology (2018)
-
Twist as a new prognostic marker in hematological malignancies
Clinical and Translational Oncology (2016)
-
KIR3DL2/CpG ODN Interaction Mediates Sézary Syndrome Malignant T Cell Apoptosis
Journal of Investigative Dermatology (2015)
-
Inhibition of JAK-STAT signaling stimulates adult satellite cell function
Nature Medicine (2014)